ライフサイエンスコーパス: cardiothoracic

1 from 4.1% (upper gastrointestinal) to 16.8% (cardiothoracic).

2 es were general (29%), orthopedic (23%), and cardiothoracic (13%).

3 group of patients with clean procedures (382 cardiothoracic, 167 orthopedic, 61 vascular, and 56 othe

4 s occurred in the gastrointestinal (30.19%), cardiothoracic (19.6%), and the orthopedic (11.13%) cate

5 emnity payments per 1,000 admissions varied (cardiothoracic = $30 US dollars, women's health = $90 US

6 mic patients without diabetic history in the cardiothoracic, (adjusted odds ratio, 2.84 [1.21, 6.63])

7 Cardiothoracic adult intensive care department.

8 heart failure cardiology, electrophysiology, cardiothoracic anaesthesiology, critical care and cardia

9 esented a collaborative effort by experts in cardiothoracic and kidney transplantation from centers a

10 esented a collaborative effort by experts in cardiothoracic and liver transplantation from across the

11 ed operative mortality rates were lowest for cardiothoracic and noncardiac thoracic surgeons (7.6% ge

12 ial fibrillation (POAF) is a complication of cardiothoracic and noncardiothoracic surgery.

13 d surgical ICUs; 1 ICU had a predominance of cardiothoracic and vascular surgical patients.

14 cic surgeons (5.1% noncardiac thoracic, 5.2% cardiothoracic, and 6.1% general surgeons) (P < 0.01 for

15 cic surgeons (5.0% noncardiac thoracic, 5.3% cardiothoracic, and 6.1% general surgeons) (P < 0.01 for

16 al, nonteaching-affiliated medical-surgical, cardiothoracic, and coronary units experienced increases

17 nts without diabetic history in the cardiac, cardiothoracic, and neurosurgical intensive care units.

18 mmonly associated with the gastrointestinal, cardiothoracic, and orthopedic procedure categories, and

19 Pediatric anesthesia and cardiothoracic anesthesia have accredited fellowships, a

20 eview board, a retrospective study using the Cardiothoracic Anesthesia Patient Registry was undertake

21 The introduction of Adult Cardiothoracic Anesthesiology fellowship accreditation b

22 rspectives from cardiology, cardiac surgery, cardiothoracic anesthesiology, critical care, medical et

23 ere never transplanted died, most often from cardiothoracic causes.

24 ere never transplanted died, most often from cardiothoracic causes.

25 ohort study, all patients at a U.K. tertiary cardiothoracic center who presented between 2009 and 201

26 all adult cardiac surgery patients in all 16 cardiothoracic centers in The Netherlands from January 1

27 etween January 2003 and May 2015 across 6 UK cardiothoracic centers.

28 th heater-coolers with cases in a quarter of cardiothoracic centers.

29 A reduction in compliance of the large-sized cardiothoracic (central) arteries is an independent risk

30 SCT, offering a learning opportunity for the cardiothoracic community to highlight the most serious c

31 festations of cardiorespiratory diseases and cardiothoracic comorbidities.

32 and is crucial for guiding the management of cardiothoracic conditions.

33 ithout clinical information and recorded the cardiothoracic (CT) ratio, vascular pedicle width (VPW),

34 blood cell (RBC) transfusion requirements in cardiothoracic (CT) surgery could improve blood inventor

35 (PCI) at medical facilities without on-site cardiothoracic (CT) surgery has been established in clin

36 donation after circulatory death, history of cardiothoracic disease, diabetes history, and terminal c

37 initial imaging evaluation of patients with cardiothoracic disease, knowledge of these basic princip

38 ith the identification of obvious and subtle cardiothoracic diseases.

39 Cardiothoracic Division, Umea University Hospital, Swede

40 ain clinical indications-particularly in the cardiothoracic domain-, and to review its limitations an

41 funded INfluenza Vaccine to Effectively Stop CardioThoracic Events and Decompensated (INVESTED) trial

42 The cardiothoracic findings of Proteus syndrome were diverse

43 Exclusions affected 88% of cardiothoracic ICU (CTICU) patients.

44 nt days differed by ICU (medical ICU = 55.5, cardiothoracic ICU = 25.3, surgical ICU = 40.2; p < .001

45 Cardiothoracic ICU, tertiary university hospital.

46 Nineteen-bed cardiothoracic ICU.

47 trauma patients) and ICU subtypes (88.6% for cardiothoracic ICUs to 93.5% for medical ICUs).

48 hildren were included from the pediatric and cardiothoracic ICUs who were greater than 37 weeks gesta

49 It is important for cardiothoracic imagers to understand this classification

50 tional radiology) to 63.1% (breast imaging); cardiothoracic imagers were more commonly early career r

51 n, n = 23; average age = 24 years) underwent cardiothoracic imaging (routine chest CT, CT pulmonary a

52 adiology (SERAM), and the Spanish Society of Cardiothoracic Imaging (SEICAT).

53 e imaging for 117 patients who had undergone cardiothoracic imaging and for 100 healthy volunteers, w

54 cle is published synchronously in Radiology: Cardiothoracic Imaging and Journal of Cardiovascular Com

55 CD CT) has increasingly garnered interest in cardiothoracic imaging due to its high spatial resolutio

56 rk, we sought to delineate the prevalence of cardiothoracic imaging findings of Proteus syndrome in a

57 ince its inaugural issue in 2019, Radiology: Cardiothoracic Imaging has disseminated the latest scien

58 Cardiothoracic imaging plays a crucial role in the diagn

59 Radiology: Cardiothoracic Imaging publishes novel research and tech

60 Radiology: Cardiothoracic Imaging publishes research, technical dev

61 urrent review article, led by the Radiology: Cardiothoracic Imaging trainee editorial board, highligh

62 urrent review article, led by the Radiology: Cardiothoracic Imaging trainee editorial board, highligh

63 portunities to conserve contrast material in cardiothoracic imaging, including low kV and dual-energy

64 cle is published synchronously in Radiology: Cardiothoracic Imaging, Journal of Cardiovascular Comput

65 being published synchronously in Radiology: Cardiothoracic Imaging, Journal of Cardiovascular Comput

66 in 9 minutes on a self-powered treadmill, or cardiothoracic index.

67 apy or early mobilization of patients in the cardiothoracic intensive care unit and its effect on len

68 ease in B. cepacia complex infections in the cardiothoracic intensive care unit at Brigham and Women'

69 ysical therapy evaluation and treatment in a cardiothoracic intensive care unit could influence lengt

70 luster of 8 B. cepacia complex infections in cardiothoracic intensive care unit patients, which were

71 lammation and survival in patients requiring cardiothoracic intensive care.

72 uation of vasopressin infusion had undergone cardiothoracic intervention, such as coronary artery byp

73 ptic shock as well as vasoplegic shock after cardiothoracic intervention.

74 Observed patient survival after cardiothoracic interventions should ideally be placed in

75 mentation models to calculate standard fetal cardiothoracic measurements.

76 tively identified from a dataset of clinical cardiothoracic MRI examinations performed between Novemb

77 comprised members of abdominal (n = 56) and cardiothoracic (n = 54) teams attending UK thoraco-abdom

78 d out in a random order until all 5 clusters-cardiothoracic, neurosurgery, orthopedic, general, and u

79 ion can be used to model case flow through a cardiothoracic operating room and ICU.

80 characteristics including age, weight, prior cardiothoracic operation, prematurity, chromosomal abnor

81 tiveness is unknown in truncal incisions for cardiothoracic or vascular operations.

82 with a categorical neurosurgery, integrated cardiothoracic, or plastic surgery residency for policie

83 idency or categorical fellowship in plastic, cardiothoracic, or vascular surgery; and had an active e

84 For each female kidney, liver, or cardiothoracic organ transplant recipient who had had a

85 tality for recipients of a kidney, liver, or cardiothoracic organ, compared with recipients of organs

86 irths in 83%, 69%, and 79% of pregnancies in cardiothoracic organ, liver, and kidney recipients, resp

87 he benefits for the recipients of livers and cardiothoracic organs were less, but there was no disadv

88 ood glucose exceeded 200 mg/dL in 21% of all cardiothoracic patients and in 31% of diabetic patients

89 Coronary care unit boarders and cardiothoracic patients were excluded from analysis.

90 ysis (65 coronary care unit boarders and 189 cardiothoracic patients).

91 Simulations were also performed using a cardiothoracic phantom.

92 The full spectrum of prior cardiothoracic procedures in lung transplant candidates

93 present a significant problem during routine cardiothoracic procedures.

94 disagreement, an independent board-certified cardiothoracic radiologist blindly interpreted the image

95 A fellowship-trained cardiothoracic radiologist reviewed these CT images and

96 test cases, which were blindly reviewed by a cardiothoracic radiologist, who correctly interpreted al

97 d with consensus results of four independent cardiothoracic radiologists (ground truth).

98 ) Pulmonary Vasculature Patterns [PVPs] by 4 cardiothoracic radiologists and repeated for reliability

99 CT images was performed in consensus by two cardiothoracic radiologists blinded to the diagnosis.

100 Five cardiothoracic radiologists evaluated 1575 low-dose comp

101 Two fellowship-trained cardiothoracic radiologists examined chest radiographs f

102 I algorithm for assessing air trapping, five cardiothoracic radiologists retrospectively evaluated se

103 mal to distal pulmonary artery branches by 2 cardiothoracic radiologists using a 5-point modified Lik

104 six zones and examined for opacities by two cardiothoracic radiologists, and scores were collated in

105 included: (1) With PVH-Staging performed by cardiothoracic radiologists, what intra-/inter-reader va

106 healthy control images from neuroradiology, cardiothoracic radiology, and musculoskeletal radiology

107 odified Lown criteria > or =2 (OR, 5.6), and cardiothoracic ratio > or =0.6 (OR, 3.3).

108 cutoffs of vascular pedicle width >70 mm and cardiothoracic ratio >0.55 or by incorporating clinical

109 ricular dysfunction (ejection fraction <45%, cardiothoracic ratio >0.55, or pulmonary edema on chest

110 In patients with normal heart size (cardiothoracic ratio < or = 0.55), the improvement in de

111 .66 +/- 0.22 versus 0.81 +/- 0.17, P = .02), cardiothoracic ratio (0.53 +/- 0.04 versus 0.58 +/- 0.06

112 d from 20+/-9% to 31+/-11% (P<0.01), and the cardiothoracic ratio decreased from 0.61+/-0.06 to 0.57+

113 ing the objective vascular pedicle width and cardiothoracic ratio measures was 3.1 (95% confidence in

114 jection fraction, higher heart rate, greater cardiothoracic ratio, higher prevalence of left bundle b

115 Cardiothoracic ratio, left ventricular end-diastolic dia

116 exity of underlying cardiac defect, enlarged cardiothoracic ratio, previous thoracotomy/ies, body mas

117 0 mm for vascular pedicle width and 0.55 for cardiothoracic ratio, radiologists' accuracy in differen

118 During 482+/-161 days of follow-up, cardiothoracic ratio, SDNN, left ventricular end-systoli

119 sodium and higher creatinine levels; higher cardiothoracic ratio; nonsustained ventricular tachycard

120 Their left ventricular dimensions, cardiothoracic ratios, and pressure-volume loop analyses

121 +/- 12; 41 men), the Cohen kappa among four cardiothoracic readers for detecting wall motion abnorma

122 pendently reviewed by two fellowship-trained cardiothoracic readers.

123 Notably, all cardiothoracic subspecialty journals did not significant

124 The patient was consulted by a cardiothoracic surgeon and an interventional radiologist

125 ternotomy and stapling resection by the same cardiothoracic surgeon.

126 important" in assessing the performance of a cardiothoracic surgeon.

127 ODS AND Projections of supply and demand for cardiothoracic surgeons are based on analysis of populat

128 grafting, there is a projected shortfall of cardiothoracic surgeons because the active supply is pro

129 acorporeal membrane oxygenation performed by cardiothoracic surgeons compared with cannulations perfo

130 By 2025, the demand for cardiothoracic surgeons could increase by 46% on the bas

131 ulation grows and ages, the number of active cardiothoracic surgeons has fallen for the first time in

132 In the United Kingdom, cardiothoracic surgeons have led the outcome reporting r

133 nty-two cannulations were performed by three cardiothoracic surgeons in 11 subjects between September

134 valuates current and future requirements for cardiothoracic surgeons in light of decreasing rates of

135 5, the survey was sent out to all consultant cardiothoracic surgeons in the United Kingdom (n=361).

136 A recent survey suggested that cardiothoracic surgeons may alter planned procedures to

137 9 patients were obtained from the Society of Cardiothoracic Surgeons of Great Britain and Ireland on

138 commendations were made by cardiologists and cardiothoracic surgeons provided with the patients' clin

139 o retired general, colorectal, vascular, and cardiothoracic surgeons that are members of the American

140 ation model, we project the future supply of cardiothoracic surgeons under alternative assumptions ab

141 ane oxygenation canulation when performed by cardiothoracic surgeons versus medical intensivist in an

142 US cardiothoracic surgeons were then randomized to receive

143 to surgeon-specific mortality data among UK cardiothoracic surgeons who associate this with several

144 The United States is facing a shortage of cardiothoracic surgeons within the next 10 years, which

145 The objective of this survey was to assess cardiothoracic surgeons' opinions on the topic, with the

146 oracic surgeons (7.6% general surgeons, 5.6% cardiothoracic surgeons, 5.8% noncardiac thoracic surgeo

147 ith industry, together with bioengineers and cardiothoracic surgeons, adult cardiac interventionists

148 g resection, 36% by general surgeons, 39% by cardiothoracic surgeons, and 25% by noncardiac thoracic

149 , they have less access to cardiologists and cardiothoracic surgeons, and have higher rates of morbid

150 ong all 14 readers (eight radiologists, four cardiothoracic surgeons, and two vascular surgeons) were

151 edicare reimbursement in 2011 through 2015), cardiothoracic surgeons, neurosurgeons, and vascular sur

152 , to designate surgeons as general surgeons, cardiothoracic surgeons, or noncardiac thoracic surgeons

153 linary team of interventional cardiologists, cardiothoracic surgeons, radiologists, echocardiographer

154 gists, in conjunction with cardiologists and cardiothoracic surgeons.

155 randomly selected vascular, neurologic, and cardiothoracic surgeons.

156 that is linked to bypass devices used during cardiothoracic surgeries.

157 , anatomic complexity declined at sites with cardiothoracic surgery (-2%) but increased at sites with

158 dents with dry eye syndrome was found in the cardiothoracic surgery (75 %) and otorhinolaryngology (7

159 ciated heart disease (RAHD), often requiring cardiothoracic surgery (CTS).

160 Cardiology and the European Association for Cardiothoracic Surgery (ESC/EACTS) 2012 guidelines recom

161 AF diagnosed during a secondary precipitant, cardiothoracic surgery (n=131 [30%]), infection (n=102 [

162 ally greater for those treated at sites with cardiothoracic surgery (National Cardiovascular Data Reg

163 ediatric surgery (OR 0.583, P = 0.0053), (3) cardiothoracic surgery (OR 0.626, P = 0.0117), and (4) b

164 ns caused by Bipolaris spp. in postoperative cardiothoracic surgery (POCS) patients during January 20

165 dencies - neurosurgery, plastic surgery, and cardiothoracic surgery - report increased rates of infer

166 f Thoracic Surgeons-European Association for Cardiothoracic Surgery [STAT] category) and simulations

167 invasive Mycobacterium chimaera infection in cardiothoracic surgery and a possible association with c

168 601 massively transfused nontrauma patients, cardiothoracic surgery and gastrointestinal or hepato-pa

169 in urologic oncology, gynecologic oncology, cardiothoracic surgery and now in female pelvic medicine

170 who were discharged from the hospital after cardiothoracic surgery between 1992 and 2002.

171 eoperative evaluation of PPC risk before non-cardiothoracic surgery between March 2014 and January 20

172 idental PFO is common in patients undergoing cardiothoracic surgery but is not associated with increa

173 ry 1, 2007, and December 31, 2009, in all 16 cardiothoracic surgery centers in the Netherlands were i

174 based, clinical trial conducted at 22 Nordic cardiothoracic surgery centers, we randomly assigned pat

175 om a multicenter, observational study of the Cardiothoracic Surgery Clinical Trials Network, in which

176 Of the 132 patients identified in the Cardiothoracic Surgery database and at discharge from th

177 e, performed by members of the Department of Cardiothoracic Surgery from Weill Cornell Medicine at th

178 iety for Cardiology/European Association for Cardiothoracic Surgery guidelines for myocardial revascu

179 Veterans who underwent cardiothoracic surgery had the highest likelihood of LST

180 The model specific to cardiothoracic surgery had the lowest performance (AUC-P

181 nvasive surgery that guided General Surgery, Cardiothoracic Surgery has progressed with warranted ent

182 ive pulmonary complications (PPCs) after non-cardiothoracic surgery in these patients.

183 ional and included adult patients undergoing cardiothoracic surgery in which ICNB was administered wi

184 Atrial fibrillation after cardiothoracic surgery is a distinct type of acute atria

185 M. chimaera infection subsequent to cardiothoracic surgery is a novel entity that has been r

186 ep hypothermic circulatory arrest (DHCA) for cardiothoracic surgery is associated with increased risk

187 of patients undergoing PCI with and without cardiothoracic surgery on-site.

188 rd-certified physicians expand their role in cardiothoracic surgery or if patients must delay appropr

189 Among cardiothoracic surgery patients with or at risk for resp

190 Heart valve replacement in pediatric cardiothoracic surgery poses problems because convention

191 atinine during hospitalization after various cardiothoracic surgery procedures.

192 The risk of death associated with AKI after cardiothoracic surgery remains high for 10 years regardl

193 presentatives from scientific cardiology and cardiothoracic surgery societies that publish current gu

194 e effort between patients and cardiology and cardiothoracic surgery societies, a standard set of meas

195 of patients treated at sites with or without cardiothoracic surgery was evaluated with a comparative

196 Referrals for emergent cardiothoracic surgery were rare regardless of treatment

197 ajor elective gastrointestinal, vascular, or cardiothoracic surgery who were recruited from 28 Nation

198 Survival was worse among all subgroups of cardiothoracic surgery with AKI except for valve surgery

199 Among patients undergoing cardiothoracic surgery with median sternotomy, the use o

200 Three underwent revision of cardiothoracic surgery with removal of infected graft.

201 y matched controls who had undergone similar cardiothoracic surgery without thymectomy.

202 y acute liver dysfunction (in the context of cardiothoracic surgery) were evaluated.

203 derwent general, gynecologic, neurologic, or cardiothoracic surgery, 3864 were included in the intent

204 One-third had prior cardiothoracic surgery, 91% of the surgeries were electi

205 coronary intervention (PCI) without on-site cardiothoracic surgery, although compliance with these r

206 heart failure/transplant, epidemiology, and cardiothoracic surgery, as well as patient advocates, pa

207 mental cost was found in patients undergoing cardiothoracic surgery, at 2,897 USD (95% CI 530.7-5263.

208 ue to grow, especially in patients following cardiothoracic surgery, bone marrow transplantation, res

209 , and specialists in advanced heart failure, cardiothoracic surgery, cardiac pathology, immunology, a

210 s to aprotinin is low in children undergoing cardiothoracic surgery, even with multiple exposures to

211 trol participants were attending surgeons in cardiothoracic surgery, general surgery, vascular surger

212 f intermittent diaphragm contractions during cardiothoracic surgery, including controlled mechanical

213 ertension, sepsis, shock, acute lung injury, cardiothoracic surgery, mechanical ventilation, vasopres

214 clinical disciplines (pediatric cardiology, cardiothoracic surgery, nursing, anesthesia, neonatology

215 A total of 830 patients who had undergone cardiothoracic surgery, of which coronary artery bypass,

216 In patients (age 65.6 +/- 6.3 yr) undergoing cardiothoracic surgery, one phrenic nerve was stimulated

217 c approach between the Pediatric Cardiology, Cardiothoracic Surgery, Pediatric Intensive Care, and Ne

218 with pulmonary hypertension associated with cardiothoracic surgery, require therapy for right ventri

219 ng treatments such as resuscitation, complex cardiothoracic surgery, use of experimental treatments,

220 e LivaNova factory seems a likely source for cardiothoracic surgery-related severe M chimaera infecti

221 majority (53 708, 71%) treated at sites with cardiothoracic surgery.

222 rtension, sepsis, acute lung injury or after cardiothoracic surgery.

223 promise for advancing the field of pediatric cardiothoracic surgery.

224 on, and pulmonary embolism, as well as after cardiothoracic surgery.

225 sensitivity reactions in children undergoing cardiothoracic surgery.

226 morphine crystal accumulation, necessitating cardiothoracic surgery.

227 nly encountered arrhythmia that occurs after cardiothoracic surgery.

228 the cardiopulmonary health of patients after cardiothoracic surgery.

229 y participants developed a PPC following non-cardiothoracic surgery.

230 of sedative classes used, deep sedation, and cardiothoracic surgery.

231 especially in combination with case-related cardiothoracic surgery.

232 in Germany were performed in the context of cardiothoracic surgery.

233 high risk for developing PPCs following non-cardiothoracic surgery.

234 berculous mycobacterium (NTM), subsequent to cardiothoracic surgery.

235 onary intervention at sites with and without cardiothoracic surgery.

236 ve outcomes of patients with hypoxemia after cardiothoracic surgery.

237 is basically feasible in ICU patients after cardiothoracic surgery.

238 e clinical settings--eg, patients undergoing cardiothoracic surgery.

239 lococcus aureus are serious complications of cardiothoracic surgery.

240 al venous access, pacemaker implantation and cardiothoracic surgery.

241 isk factors for SSIs were diabetes and prior cardiothoracic surgery; procedure-related independent ri

242 into two groups: patients who had undergone cardiothoracic surgical (CTS) procedures prior to LTx (n

243 ped into a routine surgical approach at many cardiothoracic surgical centers.

244 ed the Australian and New Zealand Society of Cardiothoracic Surgical Database with linkage to the Nat

245 ere identified through centralized pediatric cardiothoracic surgical services in Lund and Gothenburg,

246 label, multicenter study was conducted at 17 Cardiothoracic Surgical Trials Network centers in North

247 ients with moderate or severe IMR from the 2 Cardiothoracic Surgical Trials Network IMR trials who re

248 vide support simultaneously to abdominal and cardiothoracic teams in UK multiorgan retrieval.

249 Abdominal and cardiothoracic teams showed different responses when usi

250 inal teams during Vanguard but decreased for cardiothoracic teams.

251 icantly higher anxiety for abdominal but not cardiothoracic teams.

252 ections were significantly more common among cardiothoracic than abdominal transplant recipients (p=0

253 Data from the UK Cardiothoracic Transplant Audit and UK Renal Registry we

254 We used the United Kingdom Cardiothoracic Transplant Audit database to analyze the

255 the impact of obesity on kidney, liver, and cardiothoracic transplant candidates and recipients and

256 ited, heterogeneous, observational cohort of cardiothoracic transplant patients who went on to receiv

257 Cardiothoracic transplant programs generally require tha

258 Adult (aged 18+) caregivers of 242 cardiothoracic transplant recipients (lung = 134; heart

259 increased long-term mortality in kidney and cardiothoracic transplant recipients and an increased ri

260 Cardiothoracic transplant recipients are at greatest ris

261 A cohort of 96 cardiothoracic transplant recipients was monitored postt

262 The challenges facing pediatric cardiothoracic transplantation in terms of organ supply

263 problem for medium-to-long-term survivors of cardiothoracic transplantation.

264 ces both short- and long-term outcomes after cardiothoracic transplantation.

265 imus and everolimus are increasingly used in cardiothoracic transplantation.

266 aft survival and function in all renal after cardiothoracic transplants undertaken in the United King

267 r challenge during organ transplantation and cardiothoracic, vascular and general surgery.

268 cancer (n = 43), gastrointestinal (n = 13), cardiothoracic/vascular (n = 9), and transplant (n = 9).

269 n characteristics and visualization of other cardiothoracic vasculature.